Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior

Human Molecular Genetics

Volumn 24, Issue 20, 2015, Pages 5805-5827

  Genestine, Matthieu ^a   Lin, Lulu ^a,b   Durens, Madel ^a,b   Yan, Yan ^a,b   Jiang, Yiqin ^a   Prem, Smrithi ^a   Bailoor, Kunal ^f   Kelly, Brian ^f   Sonsalla, Patricia K ^a   Matteson, Paul G ^c   Silverman, Jill ^d   Crawley, Jacqueline N ^d   Millonig, James H ^a,c   DiCicco Bloom, Emanuel ^a,b,e  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Universidad de Rutgers   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; EOMESODERMIN; NORADRENALIN; SEROTONIN; TRANSCRIPTION FACTOR SOX2; ENGRAILED 2 PROTEIN; HOMEODOMAIN PROTEIN; NERVE PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR; BRAIN REGION; BRAIN STEM; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; DEVELOPMENTAL DISORDER; ENGRAILED 2 GENE; FOREBRAIN; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; HIPPOCAMPUS; MALE; MOLECULAR PATHOLOGY; MONOAMINERGIC SYSTEM; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEUROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRIORITY JOURNAL; PROMOTER REGION; RHOMBENCEPHALON; ANIMAL; DOPAMINERGIC NERVE CELL; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SEROTONINERGIC NERVE CELL; SWIMMING;

ANIMALS; DOPAMINERGIC NEURONS; FEMALE; GENE DELETION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEUROGENESIS; NOREPINEPHRINE; PROSENCEPHALON; SEROTONERGIC NEURONS; SWIMMING;

EID: 84943790821     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv301     Document Type: Article

References (152)

1. DiCicco-Bloom, E., Lord, C., Zwaigenbaum, L., Courchesne, E., Dager, S.R., Schmitz, C., Schultz, R.T., Crawley, J. and Young, L.J. (2006) The developmental neurobiology of autism spectrum disorder. J. Neurosci., 26, 6897-6906.
2. Lord, C.J. and Spence, S.J. (2006) In Moldin, S.O. and Rubenstein, J.L.R. (eds), Understanding Autism: From Basic Neuroscience to Treatment. CRC Press, Boca Raton, FL, US, pp. 1-23.
3. Sullivan, P.F., Daly, M.J. and O'Donovan, M. (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet., 13, 537-551.
4. Purcell, S.M., Moran, J.L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O'Dushlaine, C., Chambert, K., Bergen, S.E., Kahler, A. et al. (2014) A polygenic burden of rare disruptive mutations in schizophrenia. Nature, 506, 185-190.
5. Gharani, N., Benayed, R., Mancuso, V., Brzustowicz, L.M. and Millonig, J.H. (2004) Association of the homeobox transcription factor, ENGRAILED 2, with autism spectrum disorder. Mol. Psychiatry, 9, 474-484.
6. Benayed, R., Gharani, N., Rossman, I., Mancuso, V., Lazar, G., Kamdar, S., Bruse, S.E., Tischfield, S., Smith, B.J., Zimmerman, R.A. et al. (2005) Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am. J. Hum. Genet., 77, 851-868.
7. Petit, E., Herault, J., Martineau, J., Perrot, A., Barthelemy, C., Hameury, L., Sauvage, D., Lelord, G. and Muh, J.P. (1995) Association study with two markers of a human homeogene in infantile autism. J. Med. Genet., 32, 269-274.
8. Brune, C.W., Korvatska, E., Allen-Brady, K., Cook, E.H. Jr, Dawson, G., Devlin, B., Estes, A., Hennelly, M., Hyman, S.L., McMahon, W.M. et al. (2008) Heterogeneous association between engrailed-2 and autism in the CPEA network. Am. J. Med. Genet. B Neuropsychiatr. Genet., 147B, 187-193.
9. Wang, L., Jia, M., Yue, W., Tang, F., Qu, M., Ruan, Y., Lu, T., Zhang, H., Yan, H., Liu, J. et al. (2008) Association of the ENGRAILED 2 (EN2) gene with autism in Chinese Han population. Am. J. Med. Genet. B Neuropsychiatr. Genet., 147B, 434-438.
10. Yang, P., Lung, F.W., Jong, Y.J., Hsieh, H.Y., Liang, C.L. and Juo, S.H. (2008) Association of the homeobox transcription factor gene ENGRAILED 2 with autistic disorder in Chinese children. Neuropsychobiology, 57, 3-8.
11. Malhotra, D., McCarthy, S., Michaelson, J.J., Vacic, V., Burdick, K.E., Yoon, S., Cichon, S., Corvin, A., Gary, S., Gershon, E.S. et al. (2011) High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron, 72, 951-963.
12. Choi, J., Ababon, M.R., Soliman, M., Lin, Y., Brzustowicz, L.M., Matteson, P.G. and Millonig, J.H. (2014) Autism associated gene, engrailed2, and flanking gene levels are altered in post-mortem cerebellum. PLoS One, 9, e87208.
13. Choi, J., Ababon, M.R., Matteson, P.G. and Millonig, J.H. (2012) Cut-like homeobox 1 and nuclear factor I/B mediate ENGRAILED2 autism spectrum disorder-associated haplotype function. Hum. Mol. Genet., 21, 1566-1580.
14. James, S.J., Shpyleva, S., Melnyk, S., Pavliv, O. and Pogribny, I.P. (2013) Complex epigenetic regulation of engrailed-2 (EN-2) homeobox gene in the autism cerebellum. Transl. Psychiatry, 3, e232.
15. James, S.J., Shpyleva, S., Melnyk, S., Pavliv, O. and Pogribny, I.P. (2014) Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum. Transl. Psychiatry, 4, e460.
16. Cheh, M.A., Millonig, J.H., Roselli, L.M., Ming, X., Jacobsen, E., Kamdar, S. and Wagner, G.C. (2006) En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res., 1116, 166-176.
17. Tripathi, P.P., Sgado, P., Scali, M., Viaggi, C., Casarosa, S., Simon, H.H., Vaglini, F., Corsini, G.U. and Bozzi, Y. (2009) Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. Neuroscience, 159, 842-849.
18. Brielmaier, J., Matteson, P.G., Silverman, J.L., Senerth, J.M., Kelly, S., Genestine, M., Millonig, J.H., DiCicco-Bloom, E. and Crawley, J.N. (2012) Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS One, 7, e40914.
19. Davis, C.A., Noble-Topham, S.E., Rossant, J. and Joyner, A.L. (1988) Expression of the homeo box-containing gene En-2 delineates a specific region of the developing mouse brain. Genes Dev., 2, 361-371.
20. Zec, N., Rowitch, D.H., Bitgood, M.J. and Kinney, H.C. (1997) Expression of the homeobox-containing genes EN1 and EN2 inhuman fetal midgestational medulla and cerebellum. J. Neuropathol. Exp. Neurol., 56, 236-242.
21. Hanks, M.C., Loomis, C.A., Harris, E., Tong, C.X., Anson-Cartwright, L., Auerbach, A. and Joyner, A. (1998) Drosophila engrailed can substitute for mouse Engrailed1 function in midhindbrain, but not limb development. Development, 125, 4521-4530.
22. Joyner, A.L. (1996) Engrailed, Wnt and Pax genes regulate midbrain-hindbrain development. Trends Genet., 12, 15-20.
23. Davis, C.A. and Joyner, A.L. (1988) Expression patterns of the homeo box-containing genes En-1 and En-2 and the protooncogene int-1 diverge during mouse development. Genes Dev., 2, 1736-1744.
24. Goridis, C. and Rohrer, H. (2002) Specification of catecholaminergic and serotonergic neurons. Nat. Rev. Neurosci., 3, 531-541.
25. Stankovski, L., Alvarez, C., Ouimet, T., Vitalis, T., El-Hachimi, K.H., Price, D., Deneris, E., Gaspar, P. and Cases, O. (2007) Developmental cell death is enhanced in the cerebral cortex of mice lacking the brain vesicular monoamine transporter. J. Neurosci., 27, 1315-1324.
26. Narboux-Neme, N., Angenard, G., Mosienko, V., Klempin, F., Pitychoutis, P.M., Deneris, E., Bader, M., Giros, B., Alenina, N. and Gaspar, P. (2013) Postnatal growth defects in mice with constitutive depletion of central serotonin. ACS Chem. Neurosci., 4, 171-181.
27. Singh,C., Bortolato,M.,Bali, N.,Godar,S.C., Scott,A.L.,Chen, K., Thompson, R.F. and Shih, J.C. (2013) Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice. Proc. Natl. Acad. Sci. USA, 110, 12816-12821.
28. Masuda, T., Nakagawa, S., Boku, S., Nishikawa, H., Takamura, N., Kato, A., Inoue, T. and Koyama, T. (2012) Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through beta2 receptor. Prog. Neuropsychopharmacol Biol. Psychiatry, 36, 44-51.
29. Lesch, K.P. and Waider, J. (2012) Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron, 76, 175-191.
30. Jhaveri, D.J., Mackay, E.W., Hamlin, A.S., Marathe, S.V., Nandam, L.S.,Vaidya,V.A. and Bartlett, P.F. (2010)Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J. Neurosci., 30, 2795-2806.
31. Frederick, A.L. and Stanwood, G.D. (2009) Drugs, biogenic amine targets and the developing brain. Dev. Neurosci., 31, 7-22.
32. Simon, H.H., Scholz, C. and O'Leary, D.D. (2005) Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner. Mol. Cell Neurosci., 28, 96-105.
33. Simon, H.H., Saueressig, H., Wurst, W., Goulding, M.D. and O'Leary, D.D. (2001) Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci., 21, 3126-3134.
34. Fox, S.R. and Deneris, E.S. (2012) Engrailed is required in maturing serotonin neurons to regulate the cytoarchitecture and survival of the dorsal raphe nucleus. J. Neurosci., 32, 7832-7842.
35. Sgado, P., Alberi, L., Gherbassi, D., Galasso, S.L., Ramakers, G.M., Alavian, K.N., Smidt, M.P., Dyck, R.H. and Simon, H.H. (2006) Slowprogressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc. Natl. Acad. Sci. USA, 103, 15242-15247.
36. Alavian, K.N., Sgado, P., Alberi, L., Subramaniam, S. and Simon, H.H. (2009) Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression. Neural. Dev., 4, 11.
37. Alvarez-Fischer, D., Fuchs, J., Castagner, F., Stettler, O., Massiani-Beaudoin, O., Moya, K.L., Bouillot, C., Oertel, W.H., Lombes, A., Faigle, W. et al. (2011) Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. Nat. Neurosci., 14, 1260-1266.
38. Wurst, W., Auerbach, A.B. and Joyner, A.L. (1994) Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum. Development, 120, 2065-2075.
39. Joyner, A.L., Herrup, K., Auerbach, B.A., Davis, C.A. and Rossant, J. (1991) Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science, 251, 1239-1243.
40. Wilson, S.L., Kalinovsky, A., Orvis, G.D. and Joyner, A.L. (2011) Spatially restricted and developmentally dynamic expression of engrailed genes in multiple cerebellar cell types. Cerebellum, 10, 356-372.
41. Wizenmann, A., Brunet, I., Lam, J.S., Sonnier, L., Beurdeley, M., Zarbalis, K.,Weisenhorn-Vogt, D., Weinl, C., Dwivedy, A., Joliot, A. et al. (2009) Extracellular Engrailed participates in the topographic guidance of retinal axons in vivo. Neuron, 64, 355-366.
42. Cheng, Y., Sudarov, A., Szulc, K.U., Sgaier, S.K., Stephen, D., Turnbull, D.H. and Joyner, A.L. (2010) The Engrailed homeobox genes determine the different foliation patterns in the vermis and hemispheres of the mammalian cerebellum. Development, 137, 519-529.
43. Sillitoe, R.V., Vogel, M.W. and Joyner, A.L. (2010) Engrailed homeobox genes regulate establishment of the cerebellar afferent circuit map. J. Neurosci., 30, 10015-10024.
44. Rossman, I.T., Lin, L., Morgan, K.M., Digiovine, M., Van Buskirk, E.K., Kamdar, S., Millonig, J.H. and Dicicco-Bloom, E. (2014) Engrailed2 modulates cerebellar granule neuron precursor proliferation, differentiation and insulin-like growth factor 1 signaling during postnatal development. Mol. Autism., 5, 9.
45. Sgado, P., Genovesi, S., Kalinovsky, A., Zunino, G., Macchi, F., Allegra, M., Murenu, E., Provenzano, G., Tripathi, P.P., Casarosa, S. et al. (2013) Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice:implications for autism spectrum disorders. Exp. Neurol., 247, 496-505.
46. Wise, R.A. (2004) Dopamine, learning and motivation. Nat. Rev. Neurosci., 5, 483-494.
47. Sara, S.J. (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci., 10, 211-223.
48. Brielmaier, J., Senerth, J.M., Silverman, J.L., Matteson, P.G., Millonig, J.H., DiCicco-Bloom, E. and Crawley, J.N. (2014) Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. Genes Brain Behav., 13, 286-298.
49. Castren, E., Elgersma, Y., Maffei, L. and Hagerman, R. (2012) Treatment of neurodevelopmental disorders in adulthood. J. Neurosci., 32, 14074-14079.
50. Samuels, B.A., Mendez-David, I., Faye, C., David, S.A., Pierz, K.A., Gardier, A.M., Hen, R. and David, D.J. (2014) Serotonin 1A and serotonin 4 receptors: essential mediators of the neurogenic and behavioral actions of antidepressants. Neuroscientist, pii: 1073858414561303. [Epub ahead of print].
51. Sahay, A. and Hen, R. (2007) Adult hippocampal neurogenesis in depression. Nat. Neurosci., 10, 1110-1115.
52. Pascual-Brazo, J., Baekelandt, V. and Encinas, J.M. (2014) Neurogenesis as a new target for the development of antidepressant drugs. Curr. Pharm. Des., 20, 3763-3775.
53. Eisch, A.J. and Petrik, D. (2012) Depression and hippocampal neurogenesis: a road to remission? Science, 338, 72-75.
54. David, D.J., Samuels, B.A., Rainer, Q.,Wang, J.W., Marsteller, D., Mendez, I., Drew, M., Craig, D.A., Guiard, B.P., Guilloux, J.P. et al. (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron, 62, 479-493.
55. Bylund, D.B. and Reed, A.L. (2007) Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochem. Int., 51, 246-253.
56. Olivier, J.D., Blom, T., Arentsen, T. and Homberg, J.R. (2011) The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 1400-1408.
57. Park,M.J.,Guest, C.B., Barnes,M.B.,Martin, J., Ahmad, U., York, J.M. and Freund, G.G. (2008) Blocking of beta-2 adrenergic receptors hastens recovery from hypoglycemia-associated social withdrawal. Psychoneuroendocrinology, 33, 1411-1418.
58. Bortolato, M., Chen, K., Godar, S.C., Chen, G., Wu,W., Rebrin, I., Farrell, M.R., Scott, A.L.,Wellman, C.L. and Shih, J.C. (2011) Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology, 36, 2674-2688.
59. Anderson, G.M., Freedman, D.X., Cohen, D.J., Volkmar, F.R., Hoder, E.L., McPhedran, P., Minderaa, R.B., Hansen, C.R. and Young, J.G. (1987) Whole blood serotonin in autistic and normal subjects. J. Child Psychol. Psychiatry, 28, 885-900.
60. Cook, E.H. Jr, Leventhal, B.L. and Freedman, D.X. (1988) Free serotonin in plasma: autistic children and their first-degree relatives. Biol. Psychiatry, 24, 488-491.
61. Chugani, D.C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., da Silva, E.A. and Chugani, H.T. (1997) Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann. Neurol., 42, 666-669.
62. Chugani, D.C., Muzik, O., Behen, M., Rothermel, R., Janisse, J.J., Lee, J. and Chugani, H.T. (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol., 45, 287-295.
63. Whitaker-Azmitia, P.M. (2001) Serotonin and brain development:role in human developmental diseases. Brain Res. Bull., 56, 479-485.
64. Lam, K.S.,Aman, M.G. and Arnold, L.E. (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res. Dev. Disabil., 27, 254-289.
65. Akil, M., Pierri, J.N., Whitehead, R.E., Edgar, C.L., Mohila, C., Sampson, A.R. and Lewis, D.A. (1999) Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry, 156, 1580-1589.
66. Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E. et al. (1997) Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature, 385, 634-636.
67. Bruder, G.E., Keilp, J.G., Xu, H., Shikhman, M., Schori, E., Gorman, J.M. and Gilliam, T.C. (2005) Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol. Psychiatry, 58, 901-907.
68. Berger-Sweeney, J. and Hohmann, C.F. (1997) Behavioral consequences of abnormal cortical development: insights into developmental disabilities. Behav. Brain Res., 86, 121-142.
69. Boylan, C.B., Blue, M.E. and Hohmann, C.F. (2007) Modeling early cortical serotonergic deficits in autism. Behav. Brain Res., 176, 94-108.
70. Gaspar, P., Cases, O. and Maroteaux, L. (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci., 4, 1002-1012.
71. Herlenius, E. and Lagercrantz, H. (2004) Development of neurotransmitter systems during critical periods. Exp. Neurol., 190 Suppl 1, S8-S21.
72. Hoglinger, G.U., Rizk, P., Muriel, M.P., Duyckaerts, C., Oertel, W.H., Caille, I. and Hirsch, E.C. (2004) Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat. Neurosci., 7, 726-735.
73. Andreasen, N.C. (2010) The lifetime trajectory of schizophrenia and the concept of neurodevelopment. Dialogues Clin. Neurosci., 12, 409-415.
74. Amaral, D.G., Schumann, C.M. and Nordahl, C.W. (2008) Neuroanatomy of autism. Trends Neurosci., 31, 137-145.
75. Davis, L.K., Hazlett, H.C., Librant, A.L., Nopoulos, P., Sheffield, V.C., Piven, J. and Wassink, T.H. (2008) Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am. J. Med. Genet. B Neuropsychiatr. Genet., 147B, 1145-1151.
76. Wassink, T.H., Hazlett, H.C., Epping, E.A., Arndt, S., Dager, S.R., Schellenberg, G.D., Dawson, G. and Piven, J. (2007) Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch. Gen. Psychiatry, 64, 709-717.
77. Moudy, A.M., Kunkel, D.D. and Schwartzkroin, P.A. (1993) Development of dopamine-beta-hydroxylase-positive fiber innervation of the rat hippocampus. Synapse, 15, 307-318.
78. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O. et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805-809.
79. Pinos, H., Collado, P., Rodriguez-Zafra, M., Rodriguez, C., Segovia, S. and Guillamon, A. (2001) The development of sex differences in the locus coeruleus of the rat. Brain Res. Bull., 56, 73-78.
80. Dominguez, R., Cruz-Morales, S.E., Carvalho, M.C., Xavier, M. and Brandao, M.L. (2003) Sex differences in serotonergic activity in dorsal and median raphe nucleus. Physiol. Behav., 80, 203-210.
81. Foote, S.L., Bloom, F.E. and Aston-Jones, G. (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev., 63, 844-914.
82. Oleskevich, S., Descarries, L. and Lacaille, J.C. (1989) Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat. J. Neurosci., 9, 3803-3815.
83. Blakely, R.D. and Bauman, A.L. (2000) Biogenic amine transporters:regulation in flux. Curr. Opin. Neurobiol., 10, 328-336.
84. Melander, T., Hokfelt, T., Rokaeus, A., Cuello, A.C., Oertel, W.H., Verhofstad, A. and Goldstein, M. (1986) Coexistence of galanin-like immunoreactivity with catecholamines, 5- hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci., 6, 3640-3654.
85. Sgaier, S.K., Millet, S., Villanueva, M.P., Berenshteyn, F., Song, C. and Joyner, A.L. (2005) Morphogenetic and cellular movements that shape the mouse cerebellum; insights from genetic fate mapping. Neuron, 45, 27-40.
86. Lindvall, M. and Owman, C. (1981) Autonomic nerves in the mammalian choroid plexus and their influence on the formation of cerebrospinal fluid. J. Cereb. Blood Flow Metab., 1, 245-266.
87. Szabadi, E. (2013) Functional neuroanatomy of the central noradrenergic system. J. Psychopharmacol., 27, 659-693.
88. Taneja, P., Ogier, M., Brooks-Harris, G., Schmid, D.A., Katz, D.M. and Nelson, S.B. (2009) Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J. Neurosci., 29, 12187-12195.
89. Roux, J.C., Panayotis, N., Dura, E. and Villard, L. (2010) Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice. J. Neurosci. Res., 88, 1500-1509.
90. Cheng, A., Scott, A.L., Ladenheim, B., Chen, K., Ouyang, X., Lathia, J.D., Mughal, M., Cadet, J.L., Mattson, M.P. and Shih, J.C. (2010) Monoamine oxidases regulate telencephalic neural progenitors in late embryonic and early postnatal development. J. Neurosci., 30, 10752-10762.
91. Taupin, P. (2007) BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res. Rev., 53, 198-214.
92. Bernier, P.J., Bedard, A., Vinet, J., Levesque, M. and Parent, A. (2002) Newly generated neurons in the amygdala and adjoining cortex of adult primates. Proc. Natl. Acad. Sci. USA, 99, 11464-11469.
93. von Bohlen und Halbach, O. (2011) Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus. Cell Tissue Res., 345, 1-19.
94. Lledo, P.M., Alonso, M. and Grubb, M.S. (2006) Adult neurogenesis and functional plasticity in neuronal circuits. Nat. Rev. Neurosci., 7, 179-193.
95. Kirshenbaum, G.S., Lieberman, S.R., Briner, T.J., Leonardo, E.D. and Dranovsky, A. (2014) Adolescent but not adultborn neurons are critical for susceptibility to chronic social defeat. Front Behav. Neurosci., 8, 289.
96. Eisch, A.J., Cameron, H.A., Encinas, J.M., Meltzer, L.A., Ming, G.L. and Overstreet-Wadiche, L.S. (2008) Adult neurogenesis, mental health, and mental illness: hope or hype? J. Neurosci., 28, 11785-11791.
97. Penzes, P., Cahill, M.E., Jones, K.A., VanLeeuwen, J.E. and Woolfrey, K.M. (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci., 14, 285-293.
98. Wegiel, J., Flory, M., Kuchna, I., Nowicki, K., Ma, S.Y., Imaki, H., Wegiel, J., Cohen, I.L., London, E., Brown, W.T. et al. (2014) Brain-region-specific alterations of the trajectories of neuronal volume growth throughout the lifespan in autism. Acta. Neuropathol. Commun., 2, 28.
99. Marner, L., Soborg, C. and Pakkenberg, B. (2005) Increased volume of the pigmented neurons in the locus coeruleus of schizophrenic subjects: a stereological study. J. Psychiatr Res., 39, 337-345.
100. Martchek, M., Thevarkunnel, S., Bauman, M., Blatt, G. and Kemper, T. (2006) Lack of evidence of neuropathology in the locus coeruleus in autism. Acta Neuropathol., 111, 497-499.
101. Logan, C.,Wizenmann, A., Drescher, U., Monschau, B., Bonhoeffer, F. and Lumsden, A. (1996) Rostral optic tectum acquires caudal characteristics following ectopic engrailed expression. Curr. Biol., 6, 1006-1014.
102. Shigetani,Y., Funahashi, J.I. and Nakamura,H. (1997) En-2 regulates the expression of the ligands for Eph type tyrosine kinases in chick embryonic tectum. Neurosci. Res., 27, 211-217.
103. Brunet, I., Weinl, C., Piper, M., Trembleau, A., Volovitch, M., Harris, W., Prochiantz, A. and Holt, C. (2005) The transcription factor Engrailed-2 guides retinal axons. Nature, 438, 94-98.
104. Madrigal, J.L., Feinstein, D.L. and Dello Russo, C. (2005) Norepinephrine protects cortical neurons against microglial-induced cell death. J. Neurosci. Res., 81, 390-396.
105. Patel, N.J., Chen, M.J. and Russo-Neustadt, A.A. (2010) Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons. Eur. J. Pharmacol., 633, 1-9.
106. Klempin, F., Babu, H., De Pietri Tonelli, D., Alarcon, E., Fabel, K. and Kempermann, G. (2010) Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Front Mol. Neurosci., 3, doi:10.3389/fnmol.2010.00014.
107. Takamura, N., Nakagawa, S., Masuda, T., Boku, S., Kato, A., Song, N., An, Y., Kitaichi, Y., Inoue, T., Koyama, T. et al. (2014) The effect of dopamine on adult hippocampal neurogenesis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 50, 116-124.
108. Jhaveri, D.J., Nanavaty, I., Prosper, B.W., Marathe, S., Husain, B.F., Kernie, S.G., Bartlett, P.F. and Vaidya, V.A. (2014) Opposing effects of alpha2- and beta-adrenergic receptor stimulation on quiescent neural precursor cell activity and adult hippocampal neurogenesis. PLoS One, 9, e98736.
109. Hillman, K.L., Lei, S., Doze, V.A. and Porter, J.E. (2009) Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus. Epilepsy Res., 84, 97-109.
110. Song, J., Zhong, C., Bonaguidi, M.A., Sun, G.J., Hsu, D., Gu, Y., Meletis, K., Huang, Z.J., Ge, S., Enikolopov, G. et al. (2012) Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision. Nature, 489, 150-154.
111. Kana, R.K., Libero, L.E. and Moore, M.S. (2011) Disrupted cortical connectivity theory as an explanatory model for autism spectrum disorders. Phys. Life Rev., 8, 410-437.
112. Geschwind, D.H. and Levitt, P. (2007) Autism spectrum disorders:developmental disconnection syndromes. Curr. Opin. Neurobiol., 17, 103-111.
113. Wolff, J.J., Gu, H., Gerig, G., Elison, J.T., Styner, M., Gouttard, S., Botteron, K.N., Dager, S.R., Dawson, G., Estes, A.M. et al. (2012) Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am. J. Psychiatry, 169, 589-600.
114. McPartland, J.C. and Jeste, S.S. (2015) Connectivity in context:emphasizing neurodevelopment in autism spectrum disorder. Biol. Psychiatry, 77, 772-774.
115. Matson, J.L. and Nebel-Schwalm, M.S. (2007) Comorbid psychopathology with autism spectrum disorder in children: an overview. Res. Dev. Disabil., 28, 341-352.
116. Siris, S.G., Addington, D., Azorin, J.M., Falloon, I.R., Gerlach, J. and Hirsch, S.R. (2001) Depression in schizophrenia: recognition and management in the USA. Schizophr. Res., 47, 185-197.
117. Guo, N., Yoshizaki, K., Kimura, R., Suto, F., Yanagawa, Y. and Osumi, N. (2013) A sensitive period for GABAergic interneurons in the dentate gyrus in modulating sensorimotor gating. J. Neurosci., 33, 6691-6704.
118. Samuels, B.A. and Hen, R. (2011) Neurogenesis and affective disorders. Eur. J. Neurosci., 33, 1152-1159.
119. Kempermann, G., Krebs, J. and Fabel, K. (2008) The contribution of failing adult hippocampal neurogenesis to psychiatric disorders. Curr. Opin. Psychiatry, 21, 290-295.
120. Wei, L., Meaney, M.J.,Duman, R.S. and Kaffman, A. (2011) Affiliative behavior requires juvenile, but not adult neurogenesis. J Neurosci, 31, 14335-14345.
121. Wegiel, J., Kuchna, I., Nowicki, K., Imaki, H., Wegiel, J., Marchi, E., Ma, S.Y., Chauhan, A., Chauhan, V., Bobrowicz, T.W. et al. (2010) The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol., 119, 755-770.
122. Guo,W., Allan, A.M., Zong, R., Zhang, L., Johnson, E.B., Schaller, E.G., Murthy, A.C., Goggin, S.L., Eisch, A.J., Oostra, B.A. et al. (2011) Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning. Nat. Med., 17, 559-565.
123. Amiri, A., Cho, W., Zhou, J., Birnbaum, S.G., Sinton, C.M., McKay, R.M. and Parada, L.F. (2012) Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. J. Neurosci., 32, 5880-5890.
124. Hiramoto, T., Kang, G., Suzuki, G., Satoh, Y., Kucherlapati, R., Watanabe, Y. and Hiroi, N. (2011) Tbx1: identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model. Hum. Mol. Genet., 20, 4775-4785.
125. Tassone, F., Qi, L., Zhang, W., Hansen, R.L., Pessah, I.N. and Hertz-Picciotto, I. (2011)MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res., 4, 250-261.
126. Wei, Y.L., Li, C.X., Li, S.B., Liu, Y. and Hu, L. (2011) Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese. Behav. Brain Funct., 7, 42.
127. Simons, C.J. and vanWinkel, R. and Group. (2013) Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition. Schizophr. Bull., 39, 848-856.
128. Huang, S.Y., Lin, M.T., Lin, W.W., Huang, C.C., Shy, M.J. and Lu, R.B. (2009) Association of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the Han Chinese population. World J. Biol. Psychiatry, 10, 544-551.
129. Yu, Y.W., Tsai, S.J., Hong, C.J., Chen, T.J., Chen, M.C. and Yang, C.W. (2005) Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology, 30, 1719-1723.
130. Kunugi, H., Ishida, S., Kato, T., Tatsumi, M., Sakai, T., Hattori, M., Hirose, T. and Nanko, S. (1999) A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol. Psychiatry, 4, 393-395.
131. Bayles, R., Baker, E., Eikelis, N., El-Osta, A. and Lambert, G. (2010) Histone modifications regulate the norepinephrine transporter gene. Cell Cycle, 9, 4600-4601.
132. Gruss, M. and Braun, K. (2001) Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. Neural Plast., 8, 285-298.
133. Sekiguchi, H., Iritani, S., Habuchi, C., Torii, Y., Kuroda, K., Kaibuchi, K. and Ozaki, N. (2011) Impairment of the tyrosine hydroxylase neuronal network in the orbitofrontal cortex of a genetically modified mouse model of schizophrenia. Brain Res., 1392, 47-53.
134. Altamura, C., Dell'Acqua, M.L., Moessner, R., Murphy, D.L., Lesch, K.P. and Persico, A.M. (2007) Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb. Cortex, 17, 1394-1401.
135. Murcia, C.L., Gulden, F. and Herrup, K. (2005) A question of balance: a proposal for new mouse models of autism. Int. J. Dev. Neurosci., 23, 265-275.
136. Schipul, S.E., Keller, T.A. and Just, M.A. (2011) Inter-regional brain communication and its disturbance in autism. Front Syst. Neurosci., 5, 10.
137. Usher, M., Cohen, J.D., Servan-Schreiber, D., Rajkowski, J. and Aston-Jones, G. (1999) The role of locus coeruleus in the regulation of cognitive performance. Science, 283, 549-554.
138. Berridge, C.W. and Waterhouse, B.D. (2003) The locus coeruleus- noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev., 42, 33-84.
139. Werling, D.M. and Geschwind, D.H. (2013) Sex differences in autism spectrum disorders. Curr. Opin. Neurol., 26, 146-153.
140. Abel, K.M., Drake, R. and Goldstein, J.M. (2010) Sex differences in schizophrenia. Int. Rev. Psychiatry, 22, 417-428.
141. Croen, L.A., Connors, S.L., Matevia, M., Qian, Y., Newschaffer, C. and Zimmerman, A.W. (2011) Prenatal exposure to beta2-adrenergic receptor agonists and risk of autism spectrum disorders. J. Neurodev. Disord., 3, 307-315.
142. Connors, S.L., Crowell, D.E., Eberhart, C.G., Copeland, J., Newschaffer, C.J., Spence, S.J. and Zimmerman, A.W. (2005) beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J. Child Neurol., 20, 876-884.
143. Pietrzak, R.H., Gallezot, J.D., Ding, Y.S., Henry, S., Potenza, M.N., Southwick, S.M., Krystal, J.H., Carson, R.E. and Neumeister, A. (2013) Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus. JAMA Psychiatry, 70, 1199-1205.
144. Alder, J., Fujioka, W., Lifshitz, J., Crockett, D.P. and Thakker-Varia, S. (2011) Lateral fluid percussion: model of traumatic brain injury in mice. J. Vis. Exp., doi: 10.3791/3063.
145. Rocha, M.A., Crockett, D.P.,Wong, L.Y., Richardson, J.R. and Sonsalla, P.K. (2008) Na(+)/H(+) exchanger inhibition modifies dopamine neurotransmission during normal and metabolic stress conditions. J. Neurochem., 106, 231-243.
146. Zeevalk, G.D., Manzino, L., Hoppe, J. and Sonsalla, P. (1997) In vivo vulnerability of dopamine neurons to inhibition of energy metabolism. Eur. J. Pharmacol., 320, 111-119.
147. Mairet-Coello, G., Tury, A. and DiCicco-Bloom, E. (2009) Insulin- like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclindependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex. J. Neurosci., 29, 775-788.
148. Falluel-Morel, A., Sokolowski, K., Sisti, H.M., Zhou, X., Shors, T.J. and Dicicco-Bloom, E. (2007) Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J. Neurochem., 103, 1968-1981.
149. Wagner, J.P., Black, I.B. and DiCicco-Bloom, E. (1999) Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J. Neurosci., 19, 6006-6016.
150. Sokolowski, K., Obiorah, M., Robinson, K., McCandlish, E., Buckley, B. and DiCicco-Bloom, E. (2013) Neural stem cell apoptosis after low-methylmercury exposures in postnatal hippocampus produce persistent cell loss and adolescent memory deficits. Dev. Neurobiol., 73, 936-949.
151. Cheng, Y., Black, I.B. and DiCicco-Bloom, E. (2002) Hippocampal granule neuron production and population size are regulated by levels of bFGF. Eur. J. Neurosci., 15, 3-12.
152. Paxinos, G., Franklin, K.B.J. and Franklin, K.B.J. (2001) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.